Blake 1999 Salb 180.

Methods	Study design: Randomized, double blind, cross over Study location: United States Wash‐out: 3‐14 days Exercise challenge: Treadmill for 6 min at 85% of max HR Criteria for EIB diagnosis: FEV1 fall >20% after exercise challenge
Participants	Number of subjects: 26 % of males: 65% Age range: 4‐11 years Ethnicity: 81% Caucasians, 15% Blacks, 4% Hispanic Withdrawal or drop out: 3
Interventions	Drug administration: Single dose Time of exercise challenge after drug administration: 30 min, 5:30 hours, 11:30 hours Intervention: Albuterol 180 mcg, Salmeterol 25 mcg Diskus, Salmeterol 50 mcg Diskus Control: Placebo Other drug arms: None Concomitant inhaled corticosteroid (ICS) treatment: Not allowed
Outcomes	Primary available: max FEV1 % fall, % protection, FEV1 fall AUC Secondary available: Side effects
Notes	Industry funded study
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Insufficient information
Allocation concealment (selection bias)	Unclear risk	Insufficient information
Blinding of participants and personnel (performance bias) All outcomes	Low risk	Double blind study
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Insufficient information
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Insufficient information
Selective reporting (reporting bias)	Unclear risk	Insufficient information
Other bias	Unclear risk	Insufficient information